Companies in Massachusetts

Page: 1 of 7
Region:   North America
Displaying 1-50 of 304 results Download this list
Name Symbol Market Cap ADR TSO Country IPO Year Subsector
Inotek Pharmaceuticals Corporation $95.58M United States 2015 Major Pharmaceuticals
CB Pharma Acquisition Corp. $51.42M United States 2015 Business Services
CB Pharma Acquisition Corp. n/a United States 2015 Business Services
CB Pharma Acquisition Corp. n/a United States 2015 Business Services
Flex Pharma, Inc. $309.55M United States 2015 Major Pharmaceuticals
THL Credit, Inc. n/a United States 2014 n/a
Tecogen Inc. $86.72M United States 2014 Industrial Machinery/Components
Flexion Therapeutics, Inc. $488.67M United States 2014 Major Pharmaceuticals
Genocea Biosciences, Inc. $151.98M United States 2014 Biotechnology: Biological Products (No Diagnostic Substances)
Concert Pharmaceuticals, Inc. $261.7M United States 2014 Major Pharmaceuticals
Eleven Biotherapeutics, Inc. $172.18M United States 2014 Major Pharmaceuticals
Aldeyra Therapeutics, Inc. $56.77M United States 2014 Major Pharmaceuticals
Dicerna Pharmaceuticals, Inc. $434.2M United States 2014 Major Pharmaceuticals
Cerulean Pharma Inc. $165.63M United States 2014 Major Pharmaceuticals
Akebia Therapeutics, Inc. $188.36M United States 2014 Major Pharmaceuticals
Melrose Bancorp, Inc. $39.56M United States 2014 Major Banks
Minerva Neurosciences, Inc $94.78M United States 2014 Major Pharmaceuticals
Histogenics Corporation $136.12M United States 2014 Industrial Specialties
Tokai Pharmaceuticals, Inc. $338.64M United States 2014 Major Pharmaceuticals
T2 Biosystems, Inc. $332.29M United States 2014 Medical/Dental Instruments
Zafgen, Inc. $1.03B United States 2014 Major Pharmaceuticals
Sage Therapeutics, Inc. $1.12B United States 2014 Major Pharmaceuticals
Proteon Therapeutics, Inc. $177.82M United States 2014 Biotechnology: Biological Products (No Diagnostic Substances)
CB Pharma Acquisition Corp. n/a United States 2014 n/a
Bright Horizons Family Solutions Inc. $3.35B United States 2013 Other Consumer Services
Enanta Pharmaceuticals, Inc. $669.13M United States 2013 Major Pharmaceuticals
Epizyme, Inc. $803.52M United States 2013 Major Pharmaceuticals
bluebird bio, Inc. $3.1B United States 2013 Biotechnology: Biological Products (No Diagnostic Substances)
Agios Pharmaceuticals, Inc. $3.99B United States 2013 Major Pharmaceuticals
Foundation Medicine, Inc. $1.36B United States 2013 Medical Specialities
BIND Therapeutics, Inc. $100.28M United States 2013 Major Pharmaceuticals
Endurance International Group Holdings, Inc. $2.47B United States 2013 Computer Software: Prepackaged Software
Acceleron Pharma Inc. $1.31B United States 2013 Biotechnology: Biological Products (No Diagnostic Substances)
Karyopharm Therapeutics Inc. $891.49M United States 2013 Major Pharmaceuticals
Houghton Mifflin Harcourt Company $2.8B United States 2013 Books
Affiliated Managers Group, Inc. n/a United States 2012 Investment Managers
Equity Commonwealth n/a United States 2012 Real Estate Investment Trusts
M/A-COM Technology Solutions Holdings, Inc. $1.8B United States 2012 Semiconductors
Brightcove Inc. $252.05M United States 2012 EDP Services
Wellesley Bancorp, Inc. $46.27M United States 2012 Banks
Exa Corporation $136.3M United States 2012 Computer Software: Prepackaged Software
Verastem, Inc. $254.69M United States 2012 Major Pharmaceuticals
TESARO, Inc. $1.93B United States 2012 Major Pharmaceuticals
Stag Industrial, Inc. $1.61B United States 2011 Real Estate Investment Trusts
Dunkin' Brands Group, Inc. $4.57B United States 2011 Restaurants
BSB Bancorp, Inc. $172.2M United States 2011 Major Banks
THL Credit, Inc. $409.91M United States 2010 n/a
AVEO Pharmaceuticals, Inc. $65.32M United States 2010 Major Pharmaceuticals
Ironwood Pharmaceuticals, Inc. $2.18B United States 2010 Major Pharmaceuticals
LPL Financial Holdings Inc. $4.33B United States 2010 Investment Bankers/Brokers/Service
*IPO year information is not available for stocks prior to 1970.